Nov 08, 2021 16:38:00

HPV vaccine for cervical cancer found to reduce cancer incidence by 90%

Kings College said that the HPV vaccine, which prevents persistent infection of human papillomavirus (HPV) associated with the development of cervical cancer, has reduced the incidence of cervical cancer by 90% in the past 10 years. It was revealed by a study by Milena Falcaro and others in London.

The effects of the national HPV vaccination program in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study --The Lancet
https://doi.org/10.1016/S0140-6736 (21) 02178-4

“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer --Cancer Research UK --Cancer news
https://news.cancerresearchuk.org/2021/11/03/the-power-of-science-hpv-vaccine-proven-to-dramatically-reduce-cervical-cancer/

HPV vaccine cuts cervical cancer cases by almost 90% – but one in ten girls still haven't been vaccinated
https://theconversation.com/hpv-vaccine-cuts-cervical-cancer-cases-by-almost-90-but-one-in-ten-girls-still-havent-been-vaccinated-170887

In 2008, the United Kingdom launched a program to provide women aged 11 to 13 years with a free HPV vaccine to prevent the development of cervical cancer. To investigate whether the program worked, Falcaro and colleagues investigated all cervical cancers diagnosed in the United Kingdom between January 2006 and June 2019.

The results showed that the incidence of cervical cancer was reduced by 90% in those who were vaccinated between the ages of 12 and 13 when the vaccine was considered to be the most effective. 'Assuming that many people continue to be vaccinated with HPV, cervical cancer is a rare disease,' said Peter Sasieni, author of the paper. It shows that it helps prevent some cancers. '

However, the academic media The Conversation, which confirmed the results of another study on cervical cancer, points out that 'about one in ten British girls is not vaccinated.' The Conversation reviewed a large study of child-related social, economic, and educational situations, and found that girls living in the most disadvantaged areas of the UK had more HPV than girls living in the most disadvantaged areas. It was found that the vaccination rate was 56% lower.

Regarding the cause of this, from an interview conducted with the girl's parents, 'the person or parents did not want vaccination', 'we were afraid of vaccination', 'we were not at school on the day of vaccination', etc. I did. From this, The Conversation said, 'The news that vaccination has a great effect is great, but I think the program to provide equal vaccines to all girls is still flawed. Improving vaccination status. We need to take more action to do this. '